Send Inquiry

Request To Call Back

Ibrutinib Capsules 140 Mg

Name: Ibrutinib Capsules 140 Mg
Brand: DRUGS AND DEVICES PHARMA PRIVATE LIMITED
Price: 9400.0 INR
Availability: InStock

Price 9400.0 INR/ Bottle

Get a Price/Quote

MOQ : 1 Box

Ibrutinib Capsules 140 Mg Specification

Packaging Type
Blister pack, carton box

Salt Composition
Ibrutinib 140 mg

Indication
Mantle Cell Lymphoma (MCL)

Brand Name
Ibrunat

Life Span
See pack for expiry

Origin of Medicine
India

Dosage Form
Capsule

Pacakaging (Quantity Per Box)
30 capsules

Drug Type
Prescription Only

Ingredients
Ibrutinib

Physical Form
Capsule

Function
Anticancer therapy

Recommended For
Adults with MCL

Dosage
140 mg daily

Dosage Guidelines
As prescribed by physician

Quantity
30 capsules

Storage Instructions
Store below 30C, dry place

Color
White & green box

Strength per Capsule
140 mg

Intended Market
Oncology use

Prescription Status
Rx only

Country of Export
India

Blister Presentation
10's blister strips

Common Brand Variant
Ibrunat 140

Administration Route
Oral

Therapeutic Class
Bruton Tyrosine Kinase Inhibitor

Schedule
Schedule H prescription

Ibrutinib Capsules 140 Mg Trade Information

Minimum Order Quantity
1 Box

Supply Ability
500 Boxes Per Month

Delivery Time
7 Days

Ibrutinib Capsules 140 Mg About

Introducing the new release: Ibrutinib Capsules 140 mg, a formidable breakthrough in anticancer therapy and a must-have for superior oncology care. Packaged in a distinctive white & green box with 30 capsules, Ibrunat 140 is designed for adults battling Mantle Cell Lymphoma (MCL). Manufactured in India, this Bruton Tyrosine Kinase Inhibitor delivers invincible efficacy and value, adhering to stringent Schedule H standards. Each Rx-only blister strip ensures optimal freshness and dosage accuracy, making it the preferred prescription choice for healthcare professionals and patients alike.

Competitive Advantages and Usage of Ibrutinib Capsules 140 Mg

Ibrutinib Capsules 140 mg offer a superior advantage in the fight against Mantle Cell Lymphoma, thanks to their advanced Bruton Tyrosine Kinase inhibition. Designed for oral administration under physician guidance, their efficacy and targeted action make them a competitive therapeutic option. Usage is strictly for adult patients under prescription, ensuring optimized dosing and minimized adverse effects. The capsules are packaged in user-friendly blister packs for reliable daily administration and quality preservation.

Ibrutinib Capsules 140 Mg: Supply, Port, and Market Exchange

Our supply ability for Ibrutinib Capsules 140 mg is formidable, with prompt outlay and international handover from major ports in India, primarily FOB Mumbai. We assure efficient exchange and steady export channels for global oncology markets, focusing on reliability for both domestic and international clientele. The handover process is streamlined, maintaining regulatory compliance and swift logistics to guarantee timely delivery and customer satisfaction across main domestic and export destinations.

FAQ's of Ibrutinib Capsules 140 Mg:

Q: How should Ibrutinib Capsules 140 mg be stored for optimal efficacy?

A: Ibrutinib Capsules should be stored below 30C in a dry place, away from direct sunlight, to maintain their stability and effectiveness until the expiry date indicated on the pack.

Q: What is the recommended usage and dosage of Ibrutinib Capsules 140 mg?

A: The recommended dosage is 140 mg orally once daily for adults, strictly under physician supervision. Never alter the dose or schedule without consulting your healthcare provider.

Q: When is Ibrutinib Capsules 140 mg prescribed?

A: Ibrutinib Capsules 140 mg are prescribed exclusively for adult patients diagnosed with Mantle Cell Lymphoma (MCL) and should only be used with a valid prescription.

Q: Where is Ibrutinib Capsules 140 mg manufactured and exported from?

A: These capsules are manufactured and supplied from India, with main ports of exchange such as Mumbai facilitating global distribution to oncology markets worldwide.

Q: What are the competitive benefits of using Ibrutinib Capsules 140 mg over other therapies?

A: Ibrutinib offers a targeted, superior therapeutic action as a Bruton Tyrosine Kinase Inhibitor, providing value and reduced adverse effects compared to conventional chemotherapies in MCL treatment.

Q: How is Ibrutinib Capsules 140 mg packaged and dispensed?

A: The capsules are securely packed in blister strips of 10, with three strips per carton (totaling 30 capsules). Dispensing is only as per Schedule H prescription guidelines.

Tell us about your requirement